ClinicalTrials.gg
Not yet recruitingNCT06718595Updated Dec 5, 2024

Study of Management of Appendicular Abscess

An observational study in Appendiceal Abscess, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-12-05.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study aims to detect indications of surgical drainage after failure Ultrasound guided percutaneous drainage This study will include any male and female above 18 years old that presented with appendicular abscess Patients with appendicular abscess above the age of 18 years old All patients with generalized peritonitis or immunocompromised patients will be excluded from the study

Read the detailed description

Prospective randomized study we will collect 30 patients diagnosed with appendicular abscess and they all will undergo Ultrasound guided percutaneous drainage of abscess and the group who will fail to insert the pigtail will undergo surgical drainage we will record the time of operation, number of cases with intraoperative complications and then follow up these patients during time of hospital stay for post operative pain and paralytic ileus

Study outcomes:

Primary outcomes:

  1. Incidence of intra operative complications
  2. Length of operations
  3. Post operative pain
  4. Incidence of intraoperative complications as injury of important structures
  5. Lenght of hospital stay
  6. Incidence of post operative complications related to surgery as wound infection, recurrence, intestinal obstruction

Secondary outcomes:

  1. Cosmotic outcomes
  2. Incidence of recurrence of pathology
  3. Patient satisfaction
02

Conditions studied

  • Appendiceal Abscess

Browse trials for

03

In context

Abscess

152 studies on the registry are indexed under Abscess; 22 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 24 observational studies indexed under Abscess.

Browse Abscess studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study will include 100 patients was diagnosed with appendicular abscess in the emergency unit, department of general surgery, faculty of medicine, Assiut university

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with appendicular abscess above the age of 18 years old

Exclusion criteria

Exclusion Criteria:

  • Generalized peritonitis and patients with signs of spreading infection, toxemia and septicemia Multi-locular appendicular abscess patients, hepatic dysfunction, renal impairment, uncontrolled patients and cardiac disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. 1-Incidence of intraoperative complications

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Brown C, Kang L, Kim ST. Percutaneous drainage of abdominal and pelvic abscesses in children. Semin Intervent Radiol. 2012 Dec;29(4):286-94. doi: 10.1055/s-0032-1330062. PubMed 24293801 ↗
  • Darwazeh G, Cunningham SC, Kowdley GC. A Systematic Review of Perforated Appendicitis and Phlegmon: Interval Appendectomy or Wait-and-See? Am Surg. 2016 Jan;82(1):11-5. PubMed 26802841 ↗
  • Tannoury J, Abboud B. Treatment options of inflammatory appendiceal masses in adults. World J Gastroenterol. 2013 Jul 7;19(25):3942-50. doi: 10.3748/wjg.v19.i25.3942. PubMed 23840138 ↗
  • Deelder JD, Richir MC, Schoorl T, Schreurs WH. How to treat an appendiceal inflammatory mass: operatively or nonoperatively? J Gastrointest Surg. 2014 Apr;18(4):641-5. doi: 10.1007/s11605-014-2460-1. Epub 2014 Feb 4. PubMed 24493295 ↗
  • Bal A, Ozkececi ZT, Turkoglu O, Ozsoy M, Celep RB, Yilmaz S, Arikan Y. Demographic characteristics and seasonal variations of acute appendicitis. Ann Ital Chir. 2015;86:539-44. PubMed 26899348 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06718595
Lead sponsor
Assiut University
Responsible party
David Mamdouh Thabet (doctor, Assiut University) — Principal investigator
First posted
Dec 5, 2024
Start date
Dec 2, 2024 (estimated)
Primary completion
Mar 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Dec 5, 2024

Study contacts

David Mamdouh Thabet, Doctor
Contact
Fadysamir380@gmail.com
01288910475

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion